+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share Price

₹31.90 -0.54 (-1.66%)
31.16% Fall from 52W High

28 Sep, 2026 1:14 PM (IST)

Biofil Chemicals & Pharmaceuticals live price: ₹31.90. It opened at ₹32 vs previous close ₹32; intraday high/low: ₹33/₹32. The 50 & 200 DMA stand at ₹32.80/₹34.70.

Biofil Chemicals & Pharmaceuticals Performance

  • Today's Low
  • ₹32
  • Today's High
  • ₹33
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹46
  • Open Price₹32
  • Previous Close₹32
  • Volume4,267
  • 50 DMA₹32.80
  • 100 DMA₹33.10
  • 200 DMA₹34.70

Biofil Chemicals & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -2.74%
  • Over 3 Month -11.56%
  • Over 6 Month + 15.04%
  • Over 1 Year -23.17%

Smart Investing Starts Here Start SIP with Biofil Chemicals & Pharmaceuticals for Steady Growth!

Invest Now

Biofil Chemicals & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 107.2
  • PEG Ratio
  • -1.3
  • Market Cap Cr
  • 52
  • P/B Ratio
  • 2.4
  • Average True Range
  • 1.6
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 48.32
  • MFI
  • 69.49

Latest Stock News Updates

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading Window

Intimation of closure of Trading window with effect from Thursday, 01st October 2026

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Change in Management

Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company , upon attaining the age of 75 (seventy-five) years.

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Scruitinizer report with voting results

Biofil Chemicals & Pharmaceuticals Financials

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹31.90
-0.54 (-1.66%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹32.70
  • 50 Day
  • ₹32.80
  • 100 Day
  • ₹33.10
  • 200 Day
  • ₹34.70

Resistance and Support

32.07 Pivot Speed
  • R3 33.80
  • R2 33.40
  • R1 32.90
  • S1 32.00
  • S2 31.60
  • S3 31.20

Biofil Chemicals & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-11 Quarterly Results
2026-05-30 Audited Results
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results

Biofil Chemicals & Pharmaceuticals Shareholding Pattern

53.13%
46.79%
0.08%

About Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals manufactures formulations in the form of injectables, eye drops, and dry syrups. The Company offers products that include antibiotics, antianalgesics, diuretics, antimalarial vitamins, antacids, and anti-inflammatory the View More
  • NSE Symbol
  • BIOFILCHEM
  • BSE Symbol
  • 524396
  • ISIN
  • INE829A01014

Similar Stocks to Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals FAQs

Biofil Chemicals & Pharmaceuticals share price is ₹31 As on 28 September, 2026 | 13:14

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹51.9 Cr As on 28 September, 2026 | 13:14

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 107.2 As on 28 September, 2026 | 13:14

The PB ratio of Biofil Chemicals & Pharmaceuticals is 2.4 As on 28 September, 2026 | 13:14

The 52 week High & Low of Biofil Chemicals & Pharmaceuticals is ₹46.3/₹25.6 respectively As on 28 September, 2026 | 13:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23